Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company also offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
Research context
Wanjia Group Holdings Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Wanjia Group Holdings Limited is currently in a long term downtrend where the price is trading 10.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.4.
Wanjia Group Holdings Limited's total revenue sank by 0.6% to $51M since the same quarter in the previous year.
Its net income has increased by 66.2% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 120.2% to $3M since the same quarter in the previous year.
Based on the above factors, Wanjia Group Holdings Limited gets an overall score of 3/5.